首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of pharmaceutical health care and sciences

缩写:

ISSN:2055-0294

e-ISSN:2055-0294

IF/分区:1.2/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引577
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Daisuke Kikuchi,Taku Obara,Ryo Obara et al. Daisuke Kikuchi et al.
Background: Schizophrenia is a psychiatric disorder characterized by hallucinations, delusions, and other symptoms. Although treatment guidelines for schizophrenia have been established in Japan, drugs are not recommended...
Li Wang,Yibo Fei,Han Qu et al. Li Wang et al.
Objective: Bevacizumab is a monoclonal antibody against vascular endothelial growth factor. It has a wide range of clinical applications in various cancers and retinal diseases. The drugs entered the Chinese market by a l...
Sitina Iyar,Girma Tekle Gebremariam,Dessale Abate Beyene et al. Sitina Iyar et al.
Background: Hemophilia is a rare genetic condition that is often overlooked and underdiagnosed, particularly in low-income countries. Long-term spontaneous joint bleeding and soft tissues can have a significant negative i...
Ryusuke Ouchi,Munenori Nagao,Shinju Suzuki et al. Ryusuke Ouchi et al.
Background: As methadone can prevent the development of opioid resistance, it has application in alleviating cancer-related pain that proves challenging to manage with other opioids. QT interval prolongation is a serious ...
Masakazu Ozaki,Toshihiko Kobayashi,Aki Fujinaga et al. Masakazu Ozaki et al.
Background: Pharmaceutical companies do not sell formulations for all diseases; thus, healthcare workers have to treat some diseases by concocting in-hospital preparations. An example is the high-concentration 2% cyclospo...
Maki Ohkubo,Kuniaki Fukuda,Shigeru Chiba et al. Maki Ohkubo et al.
Background: Nucleoside analogues (NAs) such as entecavir are required for at least 12 months when patients with resolved hepatitis B virus (HBV) infection develop HBV reactivation. Entecavir treatment does not always achi...
Atsushi Tomizawa,Takaaki Maruhashi,Akito Shibuya et al. Atsushi Tomizawa et al.
Background: We developed a bleeding risk scoring system (BRSS) using prophylactic anticoagulation therapy to comprehensively assess the risk of venous thromboembolism (VTE) in trauma patients. This study evaluated the use...
Kensuke Nakajima,Shinya Okubo,Tomoe Ohta et al. Kensuke Nakajima et al.
Background: A reduction in the brain-derived neurotrophic factor (BDNF) level in the brain causes depression, whereas an increase in its level has therapeutic benefits against depression. BDNF is synthesized in various pe...
Kanako Fujita,Noriko Kohyama,Miki Sato et al. Kanako Fujita et al.
Background: Bleeding risk factors in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI) are unclear and data on the use of antithrombotic drugs are lacking. We investigated the b...